{"id":10363,"date":"2024-05-31T02:20:31","date_gmt":"2024-05-31T02:20:31","guid":{"rendered":"https:\/\/economicherald.net\/?p=10363"},"modified":"2024-05-31T02:20:31","modified_gmt":"2024-05-31T02:20:31","slug":"asx-health-stocks-avita-soars-on-fda-green-light-for-recell-go-system","status":"publish","type":"post","link":"https:\/\/economicherald.net\/?p=10363","title":{"rendered":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System"},"content":{"rendered":"<p>FDA approves AVITA\u2019s RECELL GO System<\/p>\n<p>Wound care medical company, <a href=\"https:\/\/stockhead.com.au\/company\/avita-medical-avh\/\">AVITA Medical ASX:AVH)<\/a>, surged +13% this morning after receiving an FDA approval for its latest product, the RECELL GO System.<\/p>\n<p>The RECELL GO system basically harvests a small sample of a patient\u2019s skin cells, typically taken from a healthy area of skin. These cells are then processed to create a suspension of Spray-On Skin Cells.<\/p>\n<p>By using less donor skin, patients experience reduced pain and faster closure, with enhanced aesthetic results at the donor site, with fewer procedures needed for complete wound closure.<\/p>\n<p>This simplifies the tasks for medical professionals, making their workflow smoother and more efficient, while also guaranteeing the best possible yield and viability of cells.<\/p>\n<p>CEO Jim Corbett believes this FDA approval will revolutionise wound care, making treatment more accessible and effective.<\/p>\n<p>\u201cFDA approval of RECELL GO marks a paradigm shift in the treatment of partial-thickness and full-thickness wounds,\u201d said Corbett.<\/p>\n<p>\u201cBy streamlining processes and enhancing operational efficiency with the use of RECELL GO, clinicians can now treat a greater number of patients and more broadly experience the proven benefits of RECELL technology.\u201d<\/p>\n<p>The RECELL GO system will launch in top burn treatment centres in the US initially, with plans for broader availability in the future.<\/p>\n<p>\u00a0<\/p>\n<h2>Telix\u2019s shares jump after sharing positive trial results<\/h2>\n<p><strong><a href=\"https:\/\/stockhead.com.au\/company\/telix-pharmaceuticals-tlx\/\">Telix Pharmaceuticals (ASX:TLX)<\/a><\/strong> jumped 10% this morning after sharing more positive results from the ProstACT SELECT trial.<\/p>\n<p>This trial is testing TLX591, a therapy for metastatic castrate-resistant prostate cancer (mCRPC) that targets PSMA-positive tumours.<\/p>\n<p>The study looks at how well TLX591 works by comparing PET scans with treatment doses.<\/p>\n<p>So far, the study shows TLX591 could help patients live longer without their cancer getting worse.<\/p>\n<p>The latest data reveals a median radiographic progression-free survival (rPFS) of 8.8 months, indicating promising potential for TLX591 in treating this patient group.<\/p>\n<p>The trial involved 23 patients with progressive mCRPC who received two intravenous infusions of TLX591, spaced 14 days apart.<\/p>\n<p>Patients in the trial have varying disease burdens, with some having already undergone two prior lines of therapy.<\/p>\n<p>\u00a0<\/p>\n<h2>EZZ enters new lucrative Asian markets<\/h2>\n<p>Meanwhile, <strong><a href=\"https:\/\/stockhead.com.au\/company\/ezz-life-science-ezz\/\">EZZ Life Science (ASX:EZZ)<\/a><\/strong> has entered into a significant sales agreement with Pinehills (Hong Kong) Limited, spanning five years.<\/p>\n<p>Under the terms, Pinehills has committed to procuring EZZ-branded products worth at least $15 million within the initial 12-month period.<\/p>\n<p>Over the duration of the agreement, the annual purchase volumes are set to escalate by a minimum of 10% each year.<\/p>\n<p>EZZ says the deal represents a strategic move for EZZ, as it will facilitate the expansion of its product distribution into key markets such as China, Vietnam, and other Southeast Asian markets.<\/p>\n<p>This expansion into new territories presents significant growth opportunities for EZZ.<\/p>\n<p>\u00a0<\/p>\n<h2>PharmAust has a new CEO and CSO<\/h2>\n<p>And finally, <strong><a href=\"https:\/\/stockhead.com.au\/company\/pharmaust-paa\/\">PharmAust (ASX:PAA)<\/a><\/strong> has made key changes to its leadership team, reappointing Dr Michael Thurn as managing director and CEO, and welcoming Dr Nicky Wallis as chief scientific officer.<\/p>\n<p>Dr Wallis, a neuroscientist with extensive global experience, will lead the evaluation of monepantel for potential use in treating neurodegenerative diseases.<\/p>\n<p>These appointments mark a significant shift for the company as it aims to become a global leader in this field.<\/p>\n<p>\u00a0<\/p>\n\n<p><span class=\"mce_SELRES_start\">\ufeff<\/span><span class=\"mce_SELRES_start\"><\/span>\u00a0<br \/>\n<span class=\"et_bloom_bottom_trigger\"><\/span><\/p>\n<p>The post <a href=\"https:\/\/stockhead.com.au\/health\/asx-health-stocks-avita-soars-on-fda-green-light-for-recell-go-system\/\">ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System<\/a> appeared first on <a href=\"https:\/\/stockhead.com.au\/\">Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>FDA approves AVITA\u2019s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13% this morning after receiving an FDA approval for its latest <a href=\"https:\/\/economicherald.net\/?p=10363\" class=\"read-more-link\">[more&#8230;]<\/a><\/p>\n","protected":false},"author":0,"featured_media":10364,"comment_status":"","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-10363","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finance"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/economicherald.net\/?p=10363\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald\" \/>\n<meta property=\"og:description\" content=\"FDA approves AVITA\u2019s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13% this morning after receiving an FDA approval for its latest [more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/economicherald.net\/?p=10363\" \/>\n<meta property=\"og:site_name\" content=\"Economic Herald\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-31T02:20:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System\",\"datePublished\":\"2024-05-31T02:20:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363\"},\"wordCount\":562,\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg\",\"articleSection\":[\"Finance\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363\",\"url\":\"https:\\\/\\\/economicherald.net\\\/?p=10363\",\"name\":\"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg\",\"datePublished\":\"2024-05-31T02:20:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/economicherald.net\\\/?p=10363\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#primaryimage\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/?p=10363#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/economicherald.net\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#website\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"name\":\"Economic Herald\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/economicherald.net\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#organization\",\"name\":\"Economic Herald\",\"url\":\"https:\\\/\\\/economicherald.net\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"contentUrl\":\"https:\\\/\\\/economicherald.net\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/cropped-cropped-economicheraldlogo-1.png\",\"width\":850,\"height\":760,\"caption\":\"Economic Herald\"},\"image\":{\"@id\":\"https:\\\/\\\/economicherald.net\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/economicherald.net\/?p=10363","og_locale":"en_US","og_type":"article","og_title":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald","og_description":"FDA approves AVITA\u2019s RECELL GO System Wound care medical company, AVITA Medical ASX:AVH), surged +13% this morning after receiving an FDA approval for its latest [more...]","og_url":"https:\/\/economicherald.net\/?p=10363","og_site_name":"Economic Herald","article_published_time":"2024-05-31T02:20:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/economicherald.net\/?p=10363#article","isPartOf":{"@id":"https:\/\/economicherald.net\/?p=10363"},"author":{"name":"","@id":""},"headline":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System","datePublished":"2024-05-31T02:20:31+00:00","mainEntityOfPage":{"@id":"https:\/\/economicherald.net\/?p=10363"},"wordCount":562,"publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"image":{"@id":"https:\/\/economicherald.net\/?p=10363#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/05\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg","articleSection":["Finance"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/economicherald.net\/?p=10363","url":"https:\/\/economicherald.net\/?p=10363","name":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System - Economic Herald","isPartOf":{"@id":"https:\/\/economicherald.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/economicherald.net\/?p=10363#primaryimage"},"image":{"@id":"https:\/\/economicherald.net\/?p=10363#primaryimage"},"thumbnailUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/05\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg","datePublished":"2024-05-31T02:20:31+00:00","breadcrumb":{"@id":"https:\/\/economicherald.net\/?p=10363#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/economicherald.net\/?p=10363"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/?p=10363#primaryimage","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/05\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2024\/05\/FDA-approves-AVITAs-RECELL-GO-System.-Picture-Getty-PnvbAK.jpeg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/economicherald.net\/?p=10363#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/economicherald.net\/"},{"@type":"ListItem","position":2,"name":"ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System"}]},{"@type":"WebSite","@id":"https:\/\/economicherald.net\/#website","url":"https:\/\/economicherald.net\/","name":"Economic Herald","description":"","publisher":{"@id":"https:\/\/economicherald.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/economicherald.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/economicherald.net\/#organization","name":"Economic Herald","url":"https:\/\/economicherald.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/","url":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","contentUrl":"https:\/\/economicherald.net\/wp-content\/uploads\/2023\/10\/cropped-cropped-economicheraldlogo-1.png","width":850,"height":760,"caption":"Economic Herald"},"image":{"@id":"https:\/\/economicherald.net\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/10363","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10363"}],"version-history":[{"count":0,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/posts\/10363\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=\/wp\/v2\/media\/10364"}],"wp:attachment":[{"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10363"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10363"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/economicherald.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10363"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}